GPC1 and neoplasm: The growth of xenograft HT‐29 and HCT‐116 tumours increased plasma GPC1 protein levels while overexpression of miR‐96‐5p and miR‐149 in xenograft tumours significantly decreased plasma GPC1 protein levels in mice.